C64.1
|
Malignant neoplasm of right kidney, except renal pelvis
|
C64.2
|
Malignant neoplasm of left kidney, except renal pelvis
|
C88.2
|
Heavy chain disease
|
C88.3
|
Immunoproliferative small intestinal disease
|
C88.8
|
Other malignant immunoproliferative diseases
|
C88.9
|
Malignant immunoproliferative disease, unspecified
|
C90.10
|
Plasma cell leukemia not having achieved remission
|
C90.11
|
Plasma cell leukemia in remission
|
C90.20
|
Extramedullary plasmacytoma not having achieved remission
|
C90.21
|
Extramedullary plasmacytoma in remission
|
C90.30
|
Solitary plasmacytoma not having achieved remission
|
C90.31
|
Solitary plasmacytoma in remission
|
C91.00
|
Acute lymphoblastic leukemia not having achieved remission
|
C91.01
|
Acute lymphoblastic leukemia, in remission
|
C91.02
|
Acute lymphoblastic leukemia, in relapse
|
C91.10
|
Chronic lymphocytic leukemia of B-cell type not having achieved remission
|
C91.11
|
Chronic lymphocytic leukemia of B-cell type in remission
|
C91.12
|
Chronic lymphocytic leukemia of B-cell type in relapse
|
C91.30
|
Prolymphocytic leukemia of B-cell type not having achieved remission
|
C91.31
|
Prolymphocytic leukemia of B-cell type, in remission
|
C91.32
|
Prolymphocytic leukemia of B-cell type, in relapse
|
C91.40
|
Hairy cell leukemia not having achieved remission
|
C91.41
|
Hairy cell leukemia, in remission
|
C91.42
|
Hairy cell leukemia, in relapse
|
C91.50
|
Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission
|
C91.51
|
Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission
|
C91.52
|
Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse
|
C91.60
|
Prolymphocytic leukemia of T-cell type not having achieved remission
|
C91.61
|
Prolymphocytic leukemia of T-cell type, in remission
|
C91.62
|
Prolymphocytic leukemia of T-cell type, in relapse
|
C91.A0
|
Mature B-cell leukemia Burkitt-type not having achieved remission
|
C91.A1
|
Mature B-cell leukemia Burkitt-type, in remission
|
C91.A2
|
Mature B-cell leukemia Burkitt-type, in relapse
|
C91.Z0
|
Other lymphoid leukemia not having achieved remission
|
C91.Z1
|
Other lymphoid leukemia, in remission
|
C91.Z2
|
Other lymphoid leukemia, in relapse
|
C91.90
|
Lymphoid leukemia, unspecified not having achieved remission
|
C91.91
|
Lymphoid leukemia, unspecified, in remission
|
C91.92
|
Lymphoid leukemia, unspecified, in relapse
|
C92.00
|
Acute myeloblastic leukemia, not having achieved remission
|
C92.01
|
Acute myeloblastic leukemia, in remission
|
C92.02
|
Acute myeloblastic leukemia, in relapse
|
C92.10
|
Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
|
C92.11
|
Chronic myeloid leukemia, BCR/ABL-positive, in remission
|
C92.12
|
Chronic myeloid leukemia, BCR/ABL-positive, in relapse
|
C92.20
|
Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
|
C92.21
|
Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
|
C92.22
|
Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
|
C92.30
|
Myeloid sarcoma, not having achieved remission
|
C92.31
|
Myeloid sarcoma, in remission
|
C92.32
|
Myeloid sarcoma, in relapse
|
C92.40
|
Acute promyelocytic leukemia, not having achieved remission
|
C92.41
|
Acute promyelocytic leukemia, in remission
|
C92.42
|
Acute promyelocytic leukemia, in relapse
|
C92.50
|
Acute myelomonocytic leukemia, not having achieved remission
|
C92.51
|
Acute myelomonocytic leukemia, in remission
|
C92.52
|
Acute myelomonocytic leukemia, in relapse
|
C92.60
|
Acute myeloid leukemia with 11q23-abnormality not having achieved remission
|
C92.61
|
Acute myeloid leukemia with 11q23-abnormality in remission
|
C92.62
|
Acute myeloid leukemia with 11q23-abnormality in relapse
|
C92.A0
|
Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
|
C92.A1
|
Acute myeloid leukemia with multilineage dysplasia, in remission
|
C92.A2
|
Acute myeloid leukemia with multilineage dysplasia, in relapse
|
C92.Z0
|
Other myeloid leukemia not having achieved remission
|
C92.Z1
|
Other myeloid leukemia, in remission
|
C92.Z2
|
Other myeloid leukemia, in relapse
|
C92.90
|
Myeloid leukemia, unspecified, not having achieved remission
|
C92.91
|
Myeloid leukemia, unspecified in remission
|
C92.92
|
Myeloid leukemia, unspecified in relapse
|
C93.00
|
Acute monoblastic/monocytic leukemia, not having achieved remission
|
C93.02
|
Acute monoblastic/monocytic leukemia, in relapse
|
C93.10
|
Chronic myelomonocytic leukemia not having achieved remission
|
C94.00
|
Acute erythroid leukemia, not having achieved remission
|
C94.02
|
Acute erythroid leukemia, in relapse
|
C94.20
|
Acute megakaryoblastic leukemia not having achieved remission
|
C94.22
|
Acute megakaryoblastic leukemia, in relapse
|
C94.40
|
Acute panmyelosis with myelofibrosis not having achieved remission
|
C94.41
|
Acute panmyelosis with myelofibrosis, in remission
|
C94.42
|
Acute panmyelosis with myelofibrosis, in relapse
|
C94.6
|
Myelodysplastic disease, not classified
|
D46.0
|
Refractory anemia without ring sideroblasts, so stated
|
D46.1
|
Refractory anemia with ring sideroblasts
|
D46.20
|
Refractory anemia with excess of blasts, unspecified
|
D46.21
|
Refractory anemia with excess of blasts 1
|
D46.22
|
Refractory anemia with excess of blasts 2
|
D46.A
|
Refractory cytopenia with multilineage dysplasia
|
D46.B
|
Refractory cytopenia with multilineage dysplasia and ring sideroblasts
|
D46.C
|
Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
|
D46.4
|
Refractory anemia, unspecified
|
D46.Z
|
Other myelodysplastic syndromes
|
D46.9
|
Myelodysplastic syndrome, unspecified
|
D47.1
|
Chronic myeloproliferative disease
|
D47.Z9
|
Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
|
D47.9
|
Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified
|
D61.1
|
Drug-induced aplastic anemia
|
D61.2
|
Aplastic anemia due to other external agents
|
D61.3
|
Idiopathic aplastic anemia
|
D61.810
|
Antineoplastic chemotherapy induced pancytopenia
|
D61.811
|
Other drug-induced pancytopenia
|
D61.818
|
Other pancytopenia
|
D61.82
|
Myelophthisis
|
D61.89
|
Other specified aplastic anemias and other bone marrow failure syndromes
|
D70.0
|
Congenital agranulocytosis
|
D70.1
|
Agranulocytosis secondary to cancer chemotherapy
|
D70.2
|
Other drug-induced agranulocytosis
|
D70.4
|
Cyclic neutropenia
|
D70.8
|
Other neutropenia
|
D70.9
|
Neutropenia, unspecified
|
K12.31
|
Oral mucositis (ulcerative) due to antineoplastic therapy
|
K12.33
|
Oral mucositis (ulcerative) due to radiation
|
T45.1X5A
|
Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
|
T45.1X5D
|
Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
|
T45.1X5S
|
Adverse effect of antineoplastic and immunosuppressive drugs, sequela
|
T66.XXXA
|
Radiation sickness, unspecified, initial encounter
|
T66.XXXD
|
Radiation sickness, unspecified, subsequent encounter
|
T66.XXXS
|
Radiation sickness, unspecified, sequela
|
Z41.8
|
Encounter for other procedures for purposes other than remedying health state
|
Z48.290
|
Encounter for aftercare following bone marrow transplant
|
Z51.11
|
Encounter for antineoplastic chemotherapy
|
Z51.12
|
Encounter for antineoplastic immunotherapy
|
Z51.89
|
Encounter for other specified aftercare
|
Z52.001
|
Unspecified donor, stem cells
|
Z52.011
|
Autologous donor, stem cells
|
Z52.091
|
Other blood donor, stem cells
|
Z76.82
|
Awaiting organ transplant status
|
Z76.89
|
Persons encountering health services in other specified circumstances
|
Z91.89
|
Other specified personal risk factors, not elsewhere classified
|
Z94.81
|
Bone marrow transplant status
|
Z94.84
|
Stem cells transplant status
|